Acute Minimally Differentiated Myeloid Leukemia (M0) with Inv(3)(q21q26)

Leukemia and Lymphoma

Volumn 35, Issue 42130, 1999, Pages 627-630

  Fujisawa, Shin ^a,b   Tanabe, Juichi ^a   Harano, Hiroshi ^a   Kanamori, Heiwa ^b   Motomura, Shigeki ^b   Mohri, Hiroshi ^b   Ishigatsubo, Yoshiaki ^b  

^a YOKOSUKA KYOSAI HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

AML MO; Inv(3)(q21q26); Karyotype

Indexed keywords

CYTARABINE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 3Q; DYSPLASIA; HUMAN; HUMAN CELL; JAPAN; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PARACENTRIC CHROMOSOME INVERSION; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 3; CYTARABINE; DAUNORUBICIN; FATAL OUTCOME; HUMANS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PREDNISOLONE;

EID: 0033371801     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428199909169630     Document Type: Article

References (21)

1. Bernstein R., Pinto M. R., Behr A., Mendelow B. Chromosome 3 abnormalities in non-lymphocytic leukemia (ANLL) with a “new” inversion anomaly and a further case of homologous translocation. Blood 1982; 60: 613 – 617
2. Rowley J. D., Potter D. Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976; 47: 705 – 721
3. Lee E. J., Schiffer C. A., Tomiyasu T., Testa J. R. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis. Leukemia 1990; 4: 350 – 353
4. Suzukawa K., Parganas E., Gajjar A., Abe T., Takahashi S., Tani K., Asano S., Asou H., Kamada N., Yokota J., Morisita K., Ihle J. N. Identification of a breakpoint cluster region 3' of the Ribophorin I gene at 3q21 associated with the transcriptional activation of the EV11 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 1994; 84: 2681 – 2688
5. Secker-Walker L. M., Mehta A., Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol 1995; 91: 490 – 501
6. Grigg A. P., Gascoyne R. D., Phillips G. L., Horsman D. E. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993; 83: 158 – 165
7. Bennett J. M., Catovsky D., Daniel M-T, Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., The French-American-British (FAB) Cooperative Group. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991; 78: 325 – 329
8. Cuneo A., Ferrant A., Michaux J. L., Boogaerts M., Demuynck H., Orshoven A. V., Criel A., Stul M., Cin P. D., Hernandez J., Chatelain B., Doyen C., Louwagie A., Castoldi G., Cassiman J-J., Berghe H. V. D. L. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: Correlation with clinicobiologic findings. Blood 1995; 85: 3688 – 3694
9. Venditti A., Poeta G. D., Buccisano F., Tamburini A., Cox M. C., Stasi R., Bruno A., Aronica G., Maffei L., Suppo G., Simone M. D., Forte L., Cordero V., Postorino M., Tufilli V., Isacchi G., Masi M., Papa G., Amadori S. Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes. Blood 1997; 89: 621 – 629
10. Cohen P., Hoyer J. D., Kurtin P. J., Dewald G. W., Hanson C. A. Acute myeloid leukemia with minimal differentiation A multiple parameter study. Am J Clin Pathol 1998; 109: 32 – 38
11. Yamagata N., Shimazaki C., Kikuta T., Hirai H., Sumikuma T., Sudo Y., Ashihara E., Goto H., Inaba T., Fujita N., Nakagawa M. A translocation between 3q21 and 12q24 in a patient with minimally differentiated acute myeloid leukemia (AML-MO). Cancer Genet Cytogenet 1997; 97: 90 – 93
12. Bitter M. A., Neilly M. E., Le Beau M. M., Pearson M. G., Rowley J. D. Rearrangements of chromosome 3 involving bands 3q2 land 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 1995; 66: 1362 – 1370
13. Grigg A. P., Gascoyne R. D., Phillips G. L., Horsman D. E. Clinical, Haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993; 83: 158 – 165
14. Fonatsch C., Gudat H., Lengfelder E., Wandt H., Silling-Engelhardt G., Ludwig W. D., Thiel E., Freund M., Bodenstein H., Schwieder G., Grüneisen A., Aul C., Schnittger S., Rieder H., Haase D., Hild F. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). Leukemia 1994; 8: 1318 – 1326
15. Morishita K., Parganas E., Willman C. L., Whittaker M. H., Drabkin H., Oval J., Taetle R., Valentine M. B., Ihle J. N. Activation of EV11 gene expression in human acute myelogenous leukemias by translocations spanning 300–400 kilobase on chromosome band 3q26. Proc Natl Acad Sci USA 1992; 89: 3937 – 3941
16. De Sauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wong S. C., Kuang W. J., Oles K. J., Huitgren B., Solberg L. A., Goeddel D. V., Eaton D. L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-MPL ligand. Nature 1994; 369: 533 – 538
17. Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Holpel M. D., Burkhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F. T., Mathewes S. L., Bailey M. C., Forstrom J. W., Buddie M. M., Osborn S. G., Evans S. J., Sheppard P. O., Presnell S. R., O'Harra P. J., Hagen F. S., Roth G. J., Foster D. C. Cloning and expression of murine thrombopoietin and stimulation of platelet production in vivo. Nature 1994; 369: 568 – 571
18. Kaushanski K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstorm J. W., Buddie M. M., Oort P. J., Hagen F. S., Roth G. J., Papayannopoulou T., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568 – 571
19. Bouscary D., Fontenay-Roupie M., Cheretien S., Hardy A. C., Viguié F., Picard F., Melle J., Dreyfus F. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome. Br J Haematol 1995; 91: 425 – 127
20. Bloomfield C. D., Garson O. M., Volin L., Knuutila S., De la Chapelle A. T(1;3)(p36;q21) in acute nonlymphocytic leukemia: A new cytogenetic-clinicopathologic association. Blood 1985; 66: 1409 – 1413
21. Shi G., Weh H. J., Dührsen U., Zeller W., Hossfeld D. K. Chromosomal Abnormality inv(3)(q21q26) Associated with Multilineage Hematopoietic Progenitor Cells in Hematopoietic Malignancies. Cancer Genet Cytogenet 1997; 96: 58 – 63